Clinical Trial

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-09.
Trial Details
NCT Number NCT07412665
Lead Sponsor Beijing Geekgene Technology Co., LTD
Collaborators: Peking University Cancer Hospital & Institute
Conditions Advanced Solid Tumors
Enrollment 10 participants
Start Date 2026-06
Primary Completion 2027-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25